Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

LOUISIANA: Louisiana State University Health Sciences Center Gets About $9 Million to Develop Pneumonia Vaccine


Associated Press (10.23.11) - Wednesday, October 26, 2011

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, has awarded an LSU doctor a five-year grant of about $9 million to support work to develop a vaccine against a major cause of pneumonia in HIV-positive people. Dr. Judd Shellito of LSUHSC-New Orleans said pneumocystitis is the most common severe secondary infection for people living with HIV. The fungus that causes the condition is not affected by current antifungal drugs; it also strikes others whose immune systems are compromised, such as cancer patients and transplant recipients.


Copyright © 2011 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in October 26, 2011. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.